Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

SASS6 is involved in the proliferation of esophageal cancer and may be a novel therapeutic target

Aug. 7, 2020

Boehringer Ingelheim initiates first-in-human study of BI-764532

Aug. 7, 2020

New adenosine A2A receptor antagonists discovered by Nuvation Bio

Aug. 7, 2020

Innate Tumor Immunity discloses NLRP3 agonists

Aug. 7, 2020

Voronoi patent details RIP-1 inhibitors

Aug. 6, 2020

New HER2 inhibitors presented by Taiho Pharmaceutical

Aug. 6, 2020

Betta Pharmaceuticals divulges EGFR mutant inhibitors

Aug. 6, 2020

p53 plays role of Dr. Jekyll or Mr. Hyde in gastric cancer

Aug. 6, 2020

Huya Bioscience obtains worldwide rights to SHP-2 inhibitor

Aug. 6, 2020

SEMA3C identified as promising therapeutic target in bladder cancer

Aug. 5, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...